http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200100770-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40e710b3b324b6eb307519da1d9bfe7e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2018-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6126569e2e16bca1c4ea14038e40f27b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dc38161c76a76ac3b4509d1fcbd2187 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdd5e5ba56b318e0c66467e46236007 |
| publicationDate | 2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200100770-A |
| titleOfInvention | Treatment of inflammatory diseases |
| abstract | The present invention provides mebendazole for use in the treatment or prevention of chronic inflammatory diseases, in particular, wherein the chronic inflammatory diseases are autoimmune diseases such as sarcoidosis, systemic lupus erythematosus (SLE; systemic lupus erythematosus), Huntington's disease, end stage renal disease, systemic sclerosis (also known as scleroderma), myositis, type 1 diabetes, multiple sclerosis, Sjogren syndrome, rheumatoid arthritis, psoriasis, primary biliary cirrhosis , Autoimmune hepatitis, Grave's disease, Addison's disease, tuberculosis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, Alzheimer's disease and celiac disease. Methods for the treatment or prevention of chronic inflammatory diseases are also provided, the method comprising administering an effective amount of mebendazole or a pharmaceutical composition of mebendazole. Also provided is the use of mebendazole for the manufacture of a medicament for the treatment of chronic inflammatory diseases. |
| priorityDate | 2017-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.